VMD - Bill Gates Says the Pandemic Will Last Until 2022: 2 TSX Stocks to Buy

The COVID-19 pandemic shattered plans and shook the foundations of society in 2020. Still, hopes were high that there was a light at the end of the tunnel as we approached the New Year. Pfizer and Moderna had revealed promising results for their vaccines after the 2020 United States presidential election. Unfortunately, the vaccine rollout in Canada has left much to be desired. It has fallen far behind many of its top peers in its inoculation efforts. Bill Gates, Microsoft founder and one of the largest donors to the World Health Organization (WHO), has been vocal since the start of the pandemic. Investors would be wise to draw from his statements and focus on TSX stocks poised to thrive in this environment.

In late 2020, Gates stated that the developed world would likely find its way out of the worst of the pandemic by the end of this year. However, the developing world might not see an end to the pandemic until late 2022 or perhaps beyond that. Today, I want to look at two TSX stocks that are in a good position to thrive as the pandemic rages on.

Bill Gates says the pandemic will rage on: Why VieMed is the perfect hold

VieMed Healthcare (TSX:VMD) (NASDAQ:VMD) provides equipment and home therapy to service patients with respiratory diseases. This TSX stock had already attracted attention heading into 2020 due to its promising business. The company broke new ground with the spread of COVID-19, a highly contagious respiratory disease. Shares of VieMed have climbed 80% year over year as of mid-afternoon trading on February 11.

In early January, VieMed announced the completion of a non-invasive ventilation study. It evaluated clinical outcomes in COPD patients with chronic respiratory failure treated with non-invasive ventilation at home (NIVH) compared to those who did not. Overall, the study showed promising results for NIVH compared to the alternative.

Beyond this promising study, VieMed is well positioned to thrive in the face of the ongoing crisis. The company estimates Q4 2020 revenues between $5 million and $6 million related to the COVID-19 pandemic . Shares of this TSX stock last had a favourable price-to-earnings ratio of 14. If Bill Gates is to be believed, VieMed has room to run as this crisis presses on.

This telehealth focused TSX stock has soared during the pandemic

WELL Health (TSX:WELL) is a Vancouver-based company that owns and operates a portfolio of primary healthcare clinics that deliver healthcare-related services. Its shares have climbed over 350% year as of mid-afternoon trading on February 11. This TSX stock has surged in the face of the COVID-19 pandemic. If Bill Gates is right, its telehealth business will continue to take advantage of ongoing trends.

In Q3 2020, the company reported record revenues and gross profit due to this surge in telehealth use. Early this month , its shares spiked on news that it had completed the acquisition of CRH Medical . This acquisition grants WELL Health a promising foothold in the U.S. market. The company projects that it will contribute greatly to revenue and EBITDA growth in the quarters ahead.

The post Bill Gates Says the Pandemic Will Last Until 2022: 2 TSX Stocks to Buy appeared first on The Motley Fool Canada .

Teresa Kersten, an employee of LinkedIn, a Microsoft subsidiary, is a member of The Motley Fool’s board of directors. Fool contributor Ambrose O'Callaghan has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Microsoft and Viemed Healthcare Inc. The Motley Fool owns shares of CRH Medical. The Motley Fool recommends Moderna Inc.

The Motley Fool’s purpose is to help the world invest, better.